Date Filed | Type | Description |
10/10/2003 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
09/15/2003 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 0% stake in SangStat Medical Corporation |
09/10/2003 |
SC 13G/A
| WELLINGTON MANAGEMENT CO LLP reports a 1% stake in Sangstat Medical Corporation |
08/25/2003 |
SC 13D
| GAMCO INVESTORS, INC. ET AL reports a 2.3% stake in SangStat Medical Corporation |
08/14/2003 |
10-Q
| Quarterly Report for the period ended August 14, 2003 |
08/07/2003 |
SC 13G/A
| ORBIMED CAPITAL LLC reports a 0% stake in SangStat Medical Corporation |
08/07/2003 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 0% stake in SangStat Medical Corporation |
08/07/2003 |
SC 13G/A
| ISALY SAMUEL D reports a 0% stake in SangStat Medical Corporation |
08/04/2003 |
8-K
| Quarterly results |
07/28/2003 |
8-K
| Other events, Financial statements and exhibits, Regulation FD Disclosure |
05/14/2003 |
10-Q
| Quarterly Report for the period ended May 14, 2003 |
04/28/2003 |
8-K
| Other events, Financial statements and exhibits, Regulation FD Disclosure |
04/04/2003 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/26/2003 |
10-K
| Annual Report for the period ended December 31, 2002 |
02/14/2003 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 6.8% stake in SangStat Medical Corporation |
02/14/2003 |
SC 13G/A
| LAIRD NORTON WEALTH MANAGEMENT, INC reports a 4% stake in SANGSTAT MEDICAL CORPORATION |
02/13/2003 |
SC 13G/A
| WENTWORTH HAUSER & VIOLICH reports a 4% stake in SANGSTAT MEDICAL CORPORATION |
02/12/2003 |
SC 13G/A
| WELLINGTON MANAGEMENT CO LLP reports a 14% stake in SANGSTAT MEDICAL CORPORATION |
11/15/2002 |
8-K
| Other events, Financial statements and exhibits |
11/12/2002 |
10-Q
| Quarterly Report for the period ended September 12, 2002 |
10/21/2002 |
8-K
| Other events, Financial statements and exhibits |
08/13/2002 |
10-Q
| Quarterly Report for the period ended June 30, 2002 |
07/15/2002 |
8-K
| Other events, Financial statements and exhibits |
06/21/2002 |
SC 13D/A
| ABBOTT LABORATORIES reports a 0.8% stake in SangStat Medical Corporation |
06/10/2002 |
8-K
| Other events, Financial statements and exhibits |
05/22/2002 |
8-K
| Other events |
05/14/2002 |
10-Q/A
| Quarterly Report for the period ended March 31, 2002 [amend] |
05/13/2002 |
10-Q
| Quarterly Report for the period ended March 31, 2002 |
04/05/2002 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
04/01/2002 |
10-K
| Annual Report for the period ended December 31, 2001 |
03/08/2002 |
SC 13G/A
| WELLINGTON MANAGEMENT CO LLP reports a 12.7% stake in SANGSTAT MEDICAL CORPORATION |
02/19/2002 |
SC 13G/A
| UBS AG has filed a Schedule 13D for SANGSTAT MEDICAL CORPORATION |
02/15/2002 |
SC 13G
| STATE STREET RESEARCH & MANAGEMENT CO / reports a 6% stake in Sangstat Medical Corp. |
02/15/2002 |
SC 13G
| ORBIMED ADVISERS INC reports a 5.6% stake in SangStat Medical Corporation |
|